Skip to main content
Journal cover image

Disparities in Mpox Vaccination Among Priority Populations During the 2022 Outbreak.

Publication ,  Journal Article
Alavian, N; Mourad, A; Woodhouse, EW; Niehaus, E; Cunningham, H; Zavala, S; Kohler, P; Pappas, S; Yarrington, ME; Okeke, NL; Wolfe, CR ...
Published in: Open Forum Infect Dis
September 2023

BACKGROUND: The 2022 mpox outbreak disproportionately affected men who have sex with men and persons living with HIV (PLWH). A 2-dose mpox vaccine series was deployed in mid-2022. Structural racism and insurance status may have affected equitable vaccination. METHODS: We defined 3 cohorts: PLWH with at least 1 clinic visit between 1 July 2021 and 1 July 2022 (n = 2066), HIV preexposure prophylaxis (PrEP) recipients as of 1 January 2022 (n = 262), and all mpox-vaccinated patients in our health system between 1 July 2022 and 30 November 2022 (n = 807). We identified patients with prior diagnosed sexually transmitted infections (STIs) as having a positive test result for gonorrhea, chlamydia, or syphilis between 1 July 2021-1 July 2022. The primary outcome was receipt of at least 1 dose of mpox vaccine. RESULTS: We identified 224 (10.8%) PLWH and 50 (19.0%) PrEP patients who received at least 1 dose of mpox vaccine. Among PLWH, White race (odds ratio [OR], 1.55; 95% CI, 1.11-2.16), private insurance (OR, 1.83; 95% CI, 1.01-3.34), prior STI (OR, 3.04; 95% CI, 2.16-4.27), prior COVID-19 vaccination (OR, 3.17; 95% CI, 1.93-5.20), and prior influenza vaccination (OR, 1.42; 95% CI, 1.30-1.96) independently predicted mpox vaccination. Within the PrEP cohort, prior COVID-19 vaccination and seasonal influenza vaccination predicted mpox vaccination. Uninsured patients were vaccinated later in the outbreak than patients with private insurance (median time to vaccination, 41 days in the privately insured group vs 83 days in the uninsured group; P < .0001). CONCLUSIONS: Race, insurance status, prior STI, and previous receipt of other vaccines influenced uptake of mpox vaccine. Addressing health disparities and vaccine acceptance will be essential in improving future outbreak response.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Open Forum Infect Dis

DOI

ISSN

2328-8957

Publication Date

September 2023

Volume

10

Issue

9

Start / End Page

ofad434

Location

United States

Related Subject Headings

  • 3207 Medical microbiology
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Alavian, N., Mourad, A., Woodhouse, E. W., Niehaus, E., Cunningham, H., Zavala, S., … Stout, J. E. (2023). Disparities in Mpox Vaccination Among Priority Populations During the 2022 Outbreak. Open Forum Infect Dis, 10(9), ofad434. https://doi.org/10.1093/ofid/ofad434
Alavian, Naseem, Ahmad Mourad, Edwin W. Woodhouse, Emily Niehaus, Hayley Cunningham, Sofia Zavala, Patricia Kohler, et al. “Disparities in Mpox Vaccination Among Priority Populations During the 2022 Outbreak.Open Forum Infect Dis 10, no. 9 (September 2023): ofad434. https://doi.org/10.1093/ofid/ofad434.
Alavian N, Mourad A, Woodhouse EW, Niehaus E, Cunningham H, Zavala S, et al. Disparities in Mpox Vaccination Among Priority Populations During the 2022 Outbreak. Open Forum Infect Dis. 2023 Sep;10(9):ofad434.
Alavian, Naseem, et al. “Disparities in Mpox Vaccination Among Priority Populations During the 2022 Outbreak.Open Forum Infect Dis, vol. 10, no. 9, Sept. 2023, p. ofad434. Pubmed, doi:10.1093/ofid/ofad434.
Alavian N, Mourad A, Woodhouse EW, Niehaus E, Cunningham H, Zavala S, Kohler P, Pappas S, Yarrington ME, Okeke NL, Wolfe CR, Cox GM, Dicks KV, Stout JE. Disparities in Mpox Vaccination Among Priority Populations During the 2022 Outbreak. Open Forum Infect Dis. 2023 Sep;10(9):ofad434.
Journal cover image

Published In

Open Forum Infect Dis

DOI

ISSN

2328-8957

Publication Date

September 2023

Volume

10

Issue

9

Start / End Page

ofad434

Location

United States

Related Subject Headings

  • 3207 Medical microbiology
  • 3202 Clinical sciences